News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Antonio Calles: Cardiotoxicity of osimertinib is real
Antonio Calles/ruberinternacional.es
Feb 6, 2025, 15:29

Antonio Calles: Cardiotoxicity of osimertinib is real

Antonio Calles, Head of the Lung Cancer Unit at Hospital Ruber Internacional, shared an article Minjung Bak and colleagues authored on X:

“Cardiotoxicity of osimertinib is real. In this Korean study, osimertinib-related cardiotoxicity was 4.7%, including 3.4% requiring cardiologic intervention. Age and previous heart conditions identified. Implications for long-lasting treatment.”

Antonio Calles

The Risk and Reversibility of Osimertinib-Related Cardiotoxicity in a Real-World Population

Authors: Minjung Bak et al.

Antonio Calles: Cardiotoxicity of osimertinib is real

Antonio Calles cancer Eun Kyoung Kim Hyukjin Park Hyun Ae Jung Jihoon Kim Jin Seok Ahn Jinhyun Cho Minjung Bak Myung-Ju Ahn Nuri Lee OncoDaily Oncology Sang-Chol Lee Se-Hoon Lee Sehhoon Park Seung Woo Park Sung-A Chang Sung-Ji Park
Special Coverage
Blog
Feb 6, 2025, 15:30
Mila Ogalla Toledo: Raising awareness of the alarming increase in trends around EOCRC
Blog
Feb 6, 2025, 15:29
Antonio Calles: Cardiotoxicity of osimertinib is real
Insight
Feb 6, 2025, 15:27
Georges Gebrael: Genomic biomarkers of survival in patients with mHSPC undergoing intensified ADT
Insight
Feb 6, 2025, 15:25
Thor Halfdanarson: A good summary on the management of GEJ/gastric adenocarcinoma
Career
Feb 6, 2025, 15:23
George Kapetanakis: Honored to serve as a member of the ESMO Patient Advocates Working Group
Blog
Feb 6, 2025, 15:21
Cary Adams' important message for World Cancer Day - UICC
Positive
Feb 6, 2025, 15:20
Sebastian Szmit: My Department of Cardio-Oncology received the Highest Gold Standard Cardio-Oncology Center of Excellence
Blog
Feb 6, 2025, 15:19
Shubh Goel: Bold and unexpected collaborations can push cancer care boundaries
Science
Feb 6, 2025, 15:16
Fadila Kouhen: The TOFFEE meta-analysis of 2F-SBRT vs. 5F-SBRT for intermediate-risk prostate cancer
Blog
Feb 6, 2025, 15:13
Dario Trapani: CSO principles for phase 3 randomised clinical trials
Blog
Feb 6, 2025, 15:12
Pat Price: Taking our campaign directly to Parliament
Science
Feb 6, 2025, 15:11
Fabio Ynoe de Moraes: Transforming Oncology Care in Latin America with AI